CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients
Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This study enrolled patients who underwent R0 resection of tumor and had elevated tumor
biomarkers (CEA, CA19-9). After enroll the study, a CTC test will performed and patients who
had positive CTC will be randomly assigned to two groups. The control group will continue
follow-up until radiological recurrence appear, the treatment group will start treatment or
change the current adjuvant regimen. First endpoint is OS. The secondary endpoint is DFS,
adverse event.